Effect of dual bronchodilation on the exercise capacity of individuals with non-cystic fibrosis bronchiectasis: A randomized controlled double-blind cross-over study protocol (Preprint)
Open Access
- 9 November 2024
- journal article
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e68582
Abstract
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Bronchodilators (BDs) have been used therapeutically to improve exercise capacity in patients with other chronic respiratory diseases. However, the effect of BDs on the exercise capacity of individuals with non-cystic fibrosis bronchiectasis (NCFB) is poorly understood. Objective: To evaluate the effects of BDs on exercise capacity and thoracoabdominal kinematics in patients with NCFB. Methods: This cross-over randomized controlled trial will involve 45 outpatients with NCFB aged 18 to 59 years. They will be evaluated in three visits. On Day 1, the maximal exercise capacity (cardiopulmonary exercise test; Wpeak) will be assessed. On Day 2, individuals will be randomized to receive either BDs (ipratropium bromide 160 µg and fenoterol hydrobromide 400 µg) or a placebo and then undergo simultaneous endurance exercise capacity (constant work-rate exercise test) and thoracoabdominal kinematics (TK) (optoelectronic plethysmography) assessments. After at least one-week washout (Day 3), the individuals will repeat the same assessments as on Day 2, in reverse order. The time to the limit of tolerance (Tlim) will be obtained in both groups (the BD and placebo groups) as the primary outcome. TK will be assessed at three-time points: at rest, during unloaded exercise, and at 75%Wpeak. The total chest wall and compartmental volumes, as well as thoracoabdominal asynchrony, will be assessed. The assessors and patients will be blinded to the interventions (BDs or placebo). Data will be compared using t-tests or Wilcoxon and repeated-measures ANOVA or Friedman tests. Categorical data will be analysed using the chi-square test or Fisher's test. The associations among variables will be analysed using Pearson or Spearman correlation. The significance level will be set at 5% (P<.05). Results: The ethics approval was granted in November 2018, and a pilot study was commenced in April 2019 but was interrupted due to the COVID-19 pandemic. The study restarted in April 2022, and data collection is ongoing, which is anticipated to continue until July 2025. Publication of results is anticipated from 2025 to 2026. Conclusions: There is no evidence that bronchodilators can improve NCFB patients' exercise capacity. This trial will compare the endurance exercise capacity of the same individual with and without dual bronchodilation. If successful, this study will demonstrate that exercise capacity can be improved with the use of bronchodilators in adults with NCFB. Clinical Trial: ClinicalTrials.gov NCT05183841; https://clinicaltrials.gov/study/NCT05183841Keywords
This publication has 42 references indexed in Scilit:
- Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)The Lancet Respiratory Medicine, 2023
- Effects of elastic tape on thoracoabdominal mechanics, dyspnea, exercise capacity, and physical activity level in nonobese male subjects with COPDJournal of Applied Physiology, 2020
- A comprehensive approach to lung function in bronchiectasisRespiratory Medicine, 2018
- Comparison between the phase angle and phase shift parameters to assess thoracoabdominal asynchrony in COPD patientsJournal of Applied Physiology, 2017
- Combination inhaled corticosteroids and long-acting beta2 -agonists for children and adults with bronchiectasisCochrane Database of Systematic Reviews, 2014
- British Thoracic Society guideline for non-CF bronchiectasisThorax, 2010
- Inhaled steroids improve quality of life in patients with steady-state bronchiectasisRespiratory Medicine, 2006
- Use of the CONSORT Statement and Quality of Reports of Randomized TrialsJAMA, 2001
- ACSM's Guidelines for Exercise Testing and Prescription, 6th EditionMedicine & Science in Sports & Exercise, 2001
- Principles of Exercise Testing and InterpretationJournal of Cardiopulmonary Rehabilitation, 1987